19.12.2022 - New statistical information

Press conference - Research and Development (RD) in the Business Enterprise Sector in 2021

In 2021, private enterprises in Switzerland spent CHF 16.8 billion on their in-house research and development activities (R&D). This represented an increase of +4% per year since 2019, the year of the last survey. With a total of CHF 6.2 billion, the pharmaceutical sector invested the most in R&D in Switzerland. Almost 62 000 people were involved in R&D activities. A quarter of the workforce was made up of women.

Theme National economy / Education and science

Attributed documents


Additional Links


https://www.bfs.admin.ch/content/bfs/en/home/aktuell/neue-veroeffentlichungen.gnpdetail.2022-0526.html